SpyBiotech

SpyBiotech is located in Oxford, United Kingdom on 7600 Quorum, Oxford Business Park North. SpyBiotech is rated 5 out of 5 in the category company in United Kingdom. SpyBiotech is pioneering a powerful new approach to generate vaccines. The company was spun out from the University of Oxford in early 2017. We have raised £5 million in seed funding to date from Oxford Sciences Innovation, the capital investor for Oxford University, and GV, an independent venture capital arm of Alphabet. Conventional approaches to generate vaccines are slow and often ineffective. Our pioneering technology, the proprietary protein superglue SpyTag/SpyCatcher, enables us to develop safe and highly effective vaccines with greater ease and speed. Our ambition is to leverage the benefits of our unique platform to address major human health challenges around the world.